RENN Health review

RENN Health for mothers: our verdict

Semaglutide is advertised as low as $149 a month and tirzepatide at $199, and after previously disagreeing with itself the site now quotes the same figures on the homepage and on each drug page. Read both as floors rather than rates. There is no ceiling published, no dose ladder anywhere on the site, and the three- and six-month bundles are described as carrying stack discounts that are never quantified, so nothing on the public pages lets you work out what treatment costs once your dose settles. The clearest gap is the memberships page, which names tiers and publishes no price for any of them despite the memberships appearing to be how the programs are sold. RENN is a California-based virtual weight-loss and performance clinic that also offers NAD+ therapy, delivering medication directly to patients. The compounding pharmacies are never named, and the only coverage statement is that the website may be accessed from all fifty states, which is a claim about the website rather than about where it is licensed to treat. It runs about $149/month — toward the affordable end of what we track.

We weigh RENN Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.

What RENN Health costs, in full

• Compounded semaglutide — Monthly plan, lowest advertised rate: $149/mo
• Compounded tirzepatide — Monthly plan: $199/mo

That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.

On that last point RENN Health is no help: it doesn't break down what the monthly figure covers — whether the provider visit, shipping and any lab work are inside it or billed separately. Ask before you pay, because that answer is what decides whether a mid-range price is actually mid-range.

The medications RENN Health prescribes

RENN Health prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.

Where RENN Health fits — and where it doesn't — for mothers

A good fit if…

• the monthly cost is a real barrier and you want a low, predictable number.
• switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.

Look elsewhere if…

• you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
• you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.

Oversight, safety, and what we could verify

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

RENN Health is a genuine value play — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.